Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Torres-Lozano

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drug Safety - Case Reports|October 18, 2016
Recurrent Toxic Epidermal Necrolysis Syndrome: A Report of Two CasesClaudia Reynoso-von Drateln, Noemí Gómez-Hernández, Norma Rodríguez-Martínez, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|September 16, 2021
[Frequency and clinical characterization of chronic urticaria in a tertiary care hospital]Bianca Coronado, Itzel Vianey Ochoa-García, Carlos Torres-Lozano, et al.
International Immunopharmacology|March 22, 2005
Effect of D-limonene on immune response in BALB/c mice with lymphomaSusana Del Toro-Arreola, Edgardo Flores-Torales, Carlos Torres-Lozano, et al.
Gaceta Medica De Mexico|November 8, 2019
Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variableAna Paola Franco-Esquivias, Cristina García-De la Peña, Carlos Torres-Lozano, et al.
Gaceta Medica De Mexico|February 25, 2020
Gut microbiota in Mexican patients with common variable immunodeficiencyAna Paola Franco-Esquivias, Cristina García-De la Peña, Carlos Torres-Lozano, et al.
American Journal of Respiratory Cell and Molecular Biology|December 24, 2002
Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epitheliumSarah M Puddicombe, Carlos Torres-Lozano, Audrey Richter, et al.
Frontiers in Immunology|April 30, 2026
X-linked severe combined immunodeficiency due to <i>IL2RG</i> p.V223F variant: clinical evidence that support its pathogenicity- a case reportBricia Melissa Gutiérrez-Zepeda, Juan Carlos Lona-Reyes, Mario Ernesto Cruz-Muñoz, et al.
The Journal of Experimental Medicine|July 6, 2011
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisLuyan Liu, Satoshi Okada, Xiao-Fei Kong, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2014
BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policiesBeatriz E Marciano, Chiung-Yu Huang, Gyan Joshi, et al.
The World Allergy Organization Journal|September 5, 2020
Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelinesDésirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jorge A Luna-Pech, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Safety - Case Reports|October 18, 2016
Recurrent Toxic Epidermal Necrolysis Syndrome: A Report of Two CasesClaudia Reynoso-von Drateln, Noemí Gómez-Hernández, Norma Rodríguez-Martínez, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|September 16, 2021
[Frequency and clinical characterization of chronic urticaria in a tertiary care hospital]Bianca Coronado, Itzel Vianey Ochoa-García, Carlos Torres-Lozano, et al.
International Immunopharmacology|March 22, 2005
Effect of D-limonene on immune response in BALB/c mice with lymphomaSusana Del Toro-Arreola, Edgardo Flores-Torales, Carlos Torres-Lozano, et al.
Gaceta Medica De Mexico|November 8, 2019
Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variableAna Paola Franco-Esquivias, Cristina García-De la Peña, Carlos Torres-Lozano, et al.
Gaceta Medica De Mexico|February 25, 2020
Gut microbiota in Mexican patients with common variable immunodeficiencyAna Paola Franco-Esquivias, Cristina García-De la Peña, Carlos Torres-Lozano, et al.
American Journal of Respiratory Cell and Molecular Biology|December 24, 2002
Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epitheliumSarah M Puddicombe, Carlos Torres-Lozano, Audrey Richter, et al.
Frontiers in Immunology|April 30, 2026
X-linked severe combined immunodeficiency due to <i>IL2RG</i> p.V223F variant: clinical evidence that support its pathogenicity- a case reportBricia Melissa Gutiérrez-Zepeda, Juan Carlos Lona-Reyes, Mario Ernesto Cruz-Muñoz, et al.
The Journal of Experimental Medicine|July 6, 2011
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisLuyan Liu, Satoshi Okada, Xiao-Fei Kong, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2014
BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policiesBeatriz E Marciano, Chiung-Yu Huang, Gyan Joshi, et al.
The World Allergy Organization Journal|September 5, 2020
Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelinesDésirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jorge A Luna-Pech, et al.
Pageof 2